Neutral On Cara Therapeutics Stock (NASDAQ:CARA)
Saturday, 26 November 2022, 07:32:38
I like the capital structure of Cara Therapeutics, but the company seems incapable of turning a profit. See why I”m neutral on CARA stock.
— Seeking Alpha
Cara Therapeutics Inc (CARA) Q3 2022 Earnings Call Transcript | AlphaStreet
Tuesday, 8 November 2022, 03:18:37
Cara Therapeutics Inc (NASDAQ:CARA) Q3 2022 Earnings Call dated Nov. 07, 2022.
— AlphaStreet
Cara Therapeutics, Inc. (CARA) Q3 2022 Earnings Call Transcript
Tuesday, 8 November 2022, 02:31:01
Cara Therapeutics, Inc. (NASDAQ:NASDAQ:CARA) Q3 2022 Earnings Conference Call November 07, 2022, 16:30 ET Company Participants Matthew Murphy – Manager, Investor Relations Christopher…
— Seeking Alpha
Cara Therapeutics GAAP EPS of -$0.43 beats by $0.01, revenue of $10.81M beats by $1.95M (NASDAQ:CARA)
Monday, 7 November 2022, 22:04:00
Cara Therapeutics press release (NASDAQ:CARA): Q3 GAAP EPS of -$0.43 beats by $0.01.Revenue of $10.81M (-46.7% Y/Y) beats by $1.95M.
— Seeking Alpha
Cara Therapeutics Reports Third Quarter 2022 Financial Results
Monday, 7 November 2022, 22:01:00
– Net revenue was $16.2M for 3Q22 including profit-sharing revenue of $7.4M from KORSUVA ® (difelikefalin) injection –
— GlobeNewswire
We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.
